CBIH Unveils Cannabinoid-Based Intranasal Platform for Alzheimer's Research #Alzheimersdisease #CannabinoidScience #IntellectualProperty #ScientificInnovation #TherapeuticInnovation #Chemicals #Pharmaceutical #Biotechnology #Cannabis #Marijuana #MarijuanaStocks #Medical #Pharmaceuticals #PotStocks #Investing
Houston, Texas--(Newsfile Corp. - July 20, 2026) - Alzheimer's disease is not only a scientific challenge; it is a human crisis affecting millions of patients, families, caregivers, and healthcare systems. Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) is responding through an intranasal nanoemulsion platform designed to explore new possibilities in neurodegenerative care through cannabinoid-based and natural-compound science.CBIH's invention centers on an intranasal medicine... http://dlvr.it/TTcmmn